{"answers":{"affected":"","exploited":"There is no known exploitation of CVE-2026-83193 in the wild and no public exploit code.","fix":"No fix has been published for CVE-2026-83193 yet. Limit exposure of the affected software until one is available.","what":"CVE-2026-83193 is a high-severity vulnerability in Oracle Corporation Siebel Apps - Life Sciences, published on 15 Sep 2026. It can only be exploited from the same machine or local network, and only if a user opens a file or follows a link."},"fix_prompt":"Check this codebase for CVE-2026-83193 and fix it if it is affected.\n\nWhat it is: CVE-2026-83193 is a high-severity vulnerability in Oracle Corporation Siebel Apps - Life Sciences, published on 15 Sep 2026. It can only be exploited from the same machine or local network, and only if a user opens a file or follows a link.\nExploitation: There is no known exploitation of CVE-2026-83193 in the wild and no public exploit code.\n\nAffected product: Oracle Corporation Siebel Apps - Life Sciences. No package-level version data is available, so check the vendor advisory linked from the reference page.\n\nTask:\n1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.\n2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.\n3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.\n4. Run the tests and summarise what changed and why.\n5. If nothing in the project is affected, say so and change nothing.\n\nReference: https://insights.sbomify.com/CVE-2026-83193/ (Markdown: https://insights.sbomify.com/CVE-2026-83193/index.md)","id":"CVE-2026-83193","markdown":"https://insights.sbomify.com/CVE-2026-83193/index.md","name":"CVE-2026-83193","record":{"aliases":["GHSA-x235-c59q-95cr"],"analysis":{"component_type":"web_application","fix_type":"patch","impacts":["privilege_escalation","code_execution"],"network_reachable":"adjacent_or_local","non_default_config":false,"product_category":"Siebel CRM","requires_auth":"low_privilege","summary":"A low-privileged attacker with local access can escalate privileges to take over Siebel Apps - Life Sciences via a vulnerability requiring user interaction.","user_interaction":"required","vuln_class":"privilege_escalation"},"analysis_generated_by":"qwen3.8-flash-next","assigner":"oracle","cpe":[],"cvss":{"score":7.3,"severity":"high","source":"cna","vector":"CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H","version":"3.1"},"cwes":[{"id":"CWE-269","name":"Improper Privilege Management"}],"description":"Vulnerability in the Siebel Apps - Life Sciences product of Oracle Siebel CRM (component: Life Sciences).  Supported versions that are affected are 17.0-26.7. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Siebel Apps - Life Sciences executes to compromise Siebel Apps - Life Sciences.  Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in takeover of Siebel Apps - Life Sciences. CVSS 3.1 Base Score 7.3 (Confidentiality, Integrity and Availability impacts).  CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:H).","ecosystems":[],"exploits":{"exploitdb":0,"first_seen":null,"github_poc":0,"max_poc_stars":null,"metasploit":0,"nuclei":0,"refs":[],"tier":"none_known"},"has_fix":null,"headline":"Privilege escalation in Siebel Apps - Life Sciences","id":"CVE-2026-83193","indexable":true,"kev":null,"kind":"cve","links":{"ecosystem":null,"product":null,"products":[],"type":"privilege_escalation","year":"2026"},"n_packages":0,"n_references":1,"next":{"headline":"Privilege escalation in Oracle Depot Repair","id":"CVE-2026-83194"},"packages":[],"prev":{"headline":"Privilege escalation in Siebel CRM End User","id":"CVE-2026-83192"},"products":["Siebel Apps - Life Sciences"],"published":"2026-09-15","related":[],"sources":[{"class":"attribution","licence":"CVE Terms of Use (MITRE)","name":"CVE List","prefix":"CVE"},{"class":"attribution","licence":"CWE Terms of Use","name":"CWE (MITRE)"},{"class":"attribution","licence":"FIRST CVSS licence","name":"CVSS (FIRST)"}],"ssvc":{"automatable":"no","exploitation":"none","technical_impact":"total"},"state":"PUBLISHED","updated":"2026-09-17","vendors":["Oracle Corporation"]},"summary":"A low-privileged attacker with local access can escalate privileges to take over Siebel Apps - Life Sciences via a vulnerability requiring user interaction.","url":"https://insights.sbomify.com/CVE-2026-83193/"}